|
RNTX Rein Therapeutics Inc 1420565 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-5,838,000.00 |
| Balance Sheet |
|
Current Assets
|
$5,453,000.00 |
|
Assets
|
$26,288,000.00 |
|
Current Liabilities
|
$13,637,000.00 |
|
Liabilities
|
$14,697,000.00 |
|
Equity
|
$11,591,000.00 |
|
Shares Out
|
28039032.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,424,000.00 |
| Market Analysis |
Market Cap
|
$21,590,054.64 |
|
Price
|
$0.74 |
|
BVPS
|
0.41 |
|
PB
|
1.88 |
|
EPS
|
-0.19 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:37 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RNTX documents filed with the SEC.
RNTX Filings
Clear
